ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Galbraith, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Galbraith, T. A.

The Annals of Thoracic Surgery, Vol 55, 1115-1121, Copyright © 1993 by The Society of Thoracic Surgeons


ARTICLES

Intrapleural doxycycline control of malignant pleural effusions

LA Robinson, WH Fleming and TA Galbraith
Section of Thoracic and Cardiovascular Surgery, University of Nebraska Medical Center, Omaha 68198-2315.

The intrapleural instillation of agents for pleural sclerosis has proved effective in preventing the reaccumulation of symptomatic malignant pleural effusions. Because manufacture of the most popular agent, tetracycline, was recently discontinued, a preliminary study was undertaken to evaluate an alternative agent, doxycycline, for treating symptomatic malignant pleural effusions. From November 1991 to September 1992, 21 patients with symptomatic malignant pleural effusions have undergone overnight chest tube drainage followed by intrapleural instillation of 10 mL 1% lidocaine and then doxycycline, 500 mg in 30 mL 0.9% saline solution. The chest tube was clamped 2 hours with patient repositioning every 15 minutes. Tubes were removed when drainage was less than 50 mL/8 h. Of surviving patients, a complete objective response at 1 month was obtained in 88% (15/17), who were free of a symptomatic or radiographic recurrence of the effusion. Complications included mild pain in 23% (5/21), moderate pain requiring analgesics in 19% (4/21), and mild fever in 5% (1/21). There were no treatment-related deaths. The mean time for chest tube removal was 1.7 +/- 0.7 days after the last treatment. Based on this preliminary study, we conclude that doxycycline is a highly effective agent for the palliative treatment of symptomatic malignant pleural effusions. Its safety profile and efficacy compare favorably with those of tetracycline and other agents used for pleural sclerosis.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. H. Warren, R. Kalimi, L. M. Khodadadian, and A. W. Kim
Management of Malignant Pleural Effusions Using the Pleurx Catheter
Ann. Thorac. Surg., March 1, 2008; 85(3): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W. H. Warren, A. W. Kim, and M. J. Liptay
Identification of clinical factors predicting Pleurx (R) catheter removal in patients treated for malignant pleural effusion
Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 89 - 94.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
S. G. Tejwani, S. B. Cohen, and J. P. Bradley
Management of Morel-Lavallee Lesion of the Knee: Twenty-Seven Cases in the National Football League
Am. J. Sports Med., July 1, 2007; 35(7): 1162 - 1167.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax, May 1, 2003; 58(90002): ii29 - 38.
[Full Text]


Home page
Am. J. Roentgenol.Home page
E. M. Marom, J. J. Erasmus, J. E. Herndon II, C. Zhang, and H. P. McAdams
Usefulness of Imaging-Guided Catheter Drainage and Talc Sclerotherapy in Patients with Metastatic Gynecologic Malignancies and Symptomatic Pleural Effusions
Am. J. Roentgenol., July 1, 2002; 179(1): 105 - 108.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. B. Putnam Jr, G. L. Walsh, S. G. Swisher, J. A. Roth, D. M. Suell, A. A. Vaporciyan, W. R. Smythe, K. W. Merriman, and L. L. DeFord
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter
Ann. Thorac. Surg., February 1, 2000; 69(2): 369 - 375.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon
Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis
Radiology, January 1, 1999; 210(1): 277 - 281.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.